샘플 요청 목록

 카트 문의
시장보고서
상품코드
1782947

세계의 소외열대질환 치료 시장

Neglected Tropical Disease Treatment
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 294 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

소외열대질환 치료 세계 시장은 2030년까지 48억 달러에 달할 전망

2024년에 38억 달러로 추정되는 소외열대질환 치료 세계 시장은 2024-2030년 분석 기간 동안 CAGR 3.7%로 성장하여 2030년에는 48억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 NTD 치료제는 CAGR 4.6%를 기록하며 분석 기간 종료시에는 31억 달러에 달할 것으로 예측됩니다. NTD 백신 분야의 성장률은 분석 기간 동안 CAGR 2.1%로 추정됩니다.

미국 시장은 10억 달러로 추정, 중국은 CAGR 7.0%로 성장 예측

미국의 소외열대질환 치료 시장은 2024년에 10억 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 분석 기간인 2024-2030년 CAGR 7.0%를 기록하며 2030년에는 예측 시장 규모 9억 7,020만 달러에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 1.4%와 2.9%로 예측됩니다. 유럽에서는 독일이 CAGR 2.1%로 성장할 것으로 예측됩니다.

전 세계 소외열대질환 치료 시장 - 주요 동향 및 촉진요인 정리

소외열대질환 치료가 세계 보건의 우선순위가 된 이유

소외열대질환(Neglected Tropical Diseases, NTDs)은 주로 저소득층과 열대 지역에서 전 세계 10억 명 이상의 사람들에게 영향을 미치고 있습니다. 리슈만병, 샤가스병, 주혈흡충증, 뎅기열을 포함한 이들 질병은 역사적으로 다른 감염병에 비해 관심도, 자금도 제한적이었습니다. 그러나 세계보건기구(WHO), 빌&멜린다 게이츠 재단, 각국 정부 보건기관 등 전 세계적으로 NTDs에 대한 인식 제고와 노력으로 NTDs 치료 및 퇴치 프로그램에 대한 투자가 촉진되고 있습니다. NTDs가 공중보건에 큰 부담이 된다는 인식이 확산되면서 의약품 유통 확대, 백신 개발 프로그램, 벡터 제어 전략이 시행되고 있습니다. 또한, 제약사, 비영리단체, 정부 간의 협력을 통해 비용 효율적인 치료제의 생산과 유통을 촉진하고 감염자의 접근성을 향상시키고 있습니다. 공중 보건 정책이 NTD 퇴치를 최우선 과제로 삼으면서 치료 및 예방 솔루션 시장은 크게 성장할 것으로 예상됩니다.

NTD 치료 및 예방의 최신 발전은 무엇인가?

NTD 치료제의 연구 개발은 약물 제제, 진단 도구, 백신 후보의 획기적인 발전을 가져왔습니다. 특히 림프계 필라리아증, 토양전염성 기생충증과 같은 질병에 대한 대량 약물 투여(MDA) 프로그램의 채택은 유행지역에서 질병의 확산을 크게 감소시켰습니다. 병용요법, 장기지속형 제제를 포함한 신약 및 재창출 약물은 약제 내성을 최소화하면서 치료 효과를 향상시키고 있습니다. 또한, 유전학적, 분자생물학적 연구를 통해 리슈만병, 뎅기열 등의 질병에 대한 차세대 백신 개발이 촉진되고 있습니다. 또한, AI를 활용한 진단 및 원격 모니터링 등 디지털 헬스 기술의 통합으로 질병의 조기 발견과 치료 계획이 강화되고 있습니다. 이러한 기술 혁신은 NTD 치료 프로그램의 효과를 향상시키고, 더 나은 질병 관리와 근절을 위한 길을 열어주고 있습니다.

민관협력은 어떻게 시장 확대를 촉진하고 있는가?

NTD 치료에 대한 접근성을 확대하는 데 있어 민관 파트너십은 중요한 역할을 하고 있으며, 제약회사는 세계보건기구와 협력하여 저렴한 의약품을 개발 및 보급하고 있습니다. 많은 기업들이 의약품 기부 프로그램을 실시해 피해 지역에 저렴한 비용으로 또는 무료로 생명을 구할 수 있는 의약품을 제공하고 있습니다. 또한, 정부의 자금 지원과 보조금을 통해 새로운 치료제 연구를 장려하고, 현지 의료 인프라를 개선하여 치료 제공을 촉진하고 있습니다. 원격의료 및 모바일 헬스(mHealth) 이니셔티브의 부상으로 원격지에서의 조기 진단 및 적시 개입이 가능해져 의료 서비스 제공이 더욱 향상되고 있습니다. 전 세계적으로 NTDs 퇴치를 위한 노력이 가속화되고 있는 가운데, 이러한 파트너십을 통해 치료 접근성 및 질병 관리에 큰 진전을 이룰 수 있을 것으로 기대됩니다.

소외열대질환 치료 시장의 성장을 촉진하는 주요 요인은 무엇인가?

소외열대질환 치료 시장의 성장은 세계 보건 자금의 증가, 의약품 개발의 진전, 민관 협력의 확대 등 여러 요인에 의해 이루어지고 있습니다. 질병 퇴치 프로그램에 대한 관심이 높아지면서 연구, 진단, 백신 개발에 많은 투자가 이루어지고 있습니다. 기후 변화로 인한 부담의 증가는 매개체 감염의 지리적 확산을 확대하여 효과적인 치료 솔루션의 필요성을 더욱 높이고 있습니다. 또한, 디지털 헬스 기술과 AI 기반 진단의 통합으로 전염병 발생 지역의 질병 감시 및 치료 제공이 개선되고 있습니다. 또한, 전국민 의료보험 추진과 지역 의료제도 강화도 시장 침투를 촉진하고 있습니다. 전 세계적으로 NTDs 퇴치를 위한 노력이 지속되는 가운데, 혁신적이고 비용 효율적인 치료 솔루션 시장은 확대될 것으로 예상되며, NTDs 퇴치를 위해 큰 진전을 이룰 것으로 기대됩니다.

부문

제품 유형(NTD 치료제, NTD 백신), 질환 유형(뎅기열 질환, 광견병, 트라코마, 브룰리 궤양, 요즈병, 한센병, 샤가스병, 인간 아프리카 트리파노소마증, 리슈만편모충증, 토양 전염성 연충병, 기타 질환 유형)

조사 대상 기업 사례

  • Abbott Laboratories
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • AstraZeneca plc
  • Bayer AG
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Dr. Reddy's Laboratories Ltd.
  • Eisai Co., Ltd.
  • F. Hoffmann-La Roche Ltd
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc(GSK)
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis AG
  • Omega Diagnostics Group PLC
  • Pfizer Inc.
  • Sanofi
  • Shionogi & Co., Ltd.
  • Takeda Pharmaceutical Company Limited

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범을 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.08.12

Global Neglected Tropical Disease Treatment Market to Reach US$4.8 Billion by 2030

The global market for Neglected Tropical Disease Treatment estimated at US$3.8 Billion in the year 2024, is expected to reach US$4.8 Billion by 2030, growing at a CAGR of 3.7% over the analysis period 2024-2030. NTD Drugs, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$3.1 Billion by the end of the analysis period. Growth in the NTD Vaccines segment is estimated at 2.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.0 Billion While China is Forecast to Grow at 7.0% CAGR

The Neglected Tropical Disease Treatment market in the U.S. is estimated at US$1.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$970.2 Million by the year 2030 trailing a CAGR of 7.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.4% and 2.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Neglected Tropical Disease Treatment Market - Key Trends & Drivers Summarized

Why Is Neglected Tropical Disease Treatment a Growing Global Health Priority?

Neglected Tropical Diseases (NTDs) affect over one billion people worldwide, primarily in low-income and tropical regions. These diseases, including leishmaniasis, Chagas disease, schistosomiasis, and dengue, have historically received limited attention and funding compared to other infectious diseases. However, increased global awareness and the efforts of organizations such as the World Health Organization (WHO), the Bill & Melinda Gates Foundation, and various government health agencies have propelled investment into NTD treatment and eradication programs. The growing recognition of NTDs as a major public health burden has led to expanded drug distribution initiatives, vaccine development programs, and vector control strategies. Additionally, collaborations between pharmaceutical companies, non-profit organizations, and governments have facilitated the production and distribution of cost-effective treatments, improving accessibility for affected populations. As public health policies increasingly prioritize NTD eradication, the market for treatments and preventive solutions is expected to witness significant growth.

What Are the Latest Advances in NTD Treatment and Prevention?

Research and development in NTD treatment have led to groundbreaking advancements in drug formulations, diagnostic tools, and vaccine candidates. The adoption of mass drug administration (MDA) programs, particularly for diseases such as lymphatic filariasis and soil-transmitted helminthiasis, has significantly reduced disease prevalence in endemic regions. New and repurposed drugs, including combination therapies and long-acting formulations, have improved treatment efficacy while minimizing drug resistance. Additionally, genetic and molecular research has facilitated the development of next-generation vaccines for diseases like leishmaniasis and dengue. The integration of digital health technologies, including AI-driven diagnostics and remote monitoring, has also enhanced early disease detection and treatment planning. These innovations are improving the effectiveness of NTD treatment programs, paving the way for better disease control and potential eradication.

How Are Public-Private Partnerships Driving Market Expansion?

Public-private partnerships have played a crucial role in expanding access to NTD treatments, with pharmaceutical companies collaborating with global health organizations to develop and distribute affordable medications. Many firms have implemented drug donation programs, supplying life-saving treatments to affected regions at little or no cost. Additionally, government funding and grants have incentivized research into novel therapeutics, while local healthcare infrastructure improvements have facilitated treatment delivery. The rise of telemedicine and mobile health (mHealth) initiatives has further improved outreach, enabling early diagnosis and timely intervention in remote communities. As global efforts to eliminate NTDs gain momentum, these partnerships are expected to drive significant advancements in treatment accessibility and disease management.

What Are the Key Factors Driving Growth in the Neglected Tropical Disease Treatment Market?

The growth in the neglected tropical disease treatment market is driven by several factors, including increased global health funding, advancements in drug development, and expanding public-private collaborations. The growing focus on disease eradication programs has led to significant investments in research, diagnostics, and vaccine development. The rising burden of climate change, which has expanded the geographical spread of vector-borne diseases, has further intensified the need for effective treatment solutions. Additionally, the integration of digital health technologies and AI-driven diagnostics has improved disease surveillance and treatment delivery in endemic regions. The push for universal healthcare access and the strengthening of local healthcare systems have also facilitated greater market penetration. With sustained global efforts to combat NTDs, the market for innovative and cost-effective treatment solutions is expected to expand, making significant progress toward eliminating these diseases.

SCOPE OF STUDY:

The report analyzes the Neglected Tropical Disease Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (NTD Drugs, NTD Vaccines); Disease Type (Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease, Chagas Disease, Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Abbott Laboratories
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • AstraZeneca plc
  • Bayer AG
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Dr. Reddy's Laboratories Ltd.
  • Eisai Co., Ltd.
  • F. Hoffmann-La Roche Ltd
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc (GSK)
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis AG
  • Omega Diagnostics Group PLC
  • Pfizer Inc.
  • Sanofi
  • Shionogi & Co., Ltd.
  • Takeda Pharmaceutical Company Limited

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Neglected Tropical Disease Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Health Prioritization of NTDs Spurs Growth in Treatment Markets
    • WHO Roadmap for NTDs Strengthens Business Case for Scaled Investment in Therapies
    • Increased International Donor Funding Expands Addressable Market Opportunity for NTD Drugs
    • Advancements in Genomic and Molecular Research Drives Innovation in Targeted NTD Therapies
    • Integration of NTDs into Universal Health Coverage Plans Generates Long-Term Demand Potential
    • Cross-Sector Partnerships Between Governments, NGOs, and Pharma Accelerate Treatment Access
    • Growing Focus on One Health Approach Throws the Spotlight on Integrated Disease Management
    • Climate Change-Induced Spread of Vectors Expands Geographical Scope of NTD Markets
    • Enhanced Surveillance and Mapping Systems Drive Demand for Early-Stage Therapeutics
    • Public-Private Product Development Partnerships (PDPs) Sustain Growth in Clinical Pipelines
    • Regulatory Incentives and Priority Review Vouchers Propel Growth in R&D Investments
    • Emergence of Oral, Single-Dose Therapies Drives Adoption in Resource-Limited Settings
    • Innovations in Drug Formulations and Delivery Mechanisms Enhance Access and Patient Compliance
    • Digital Health and Remote Diagnostics Tools Generate Demand for Coordinated Care Solutions
    • Regional Disease Elimination Goals Throw the Spotlight on Scalable and Affordable Treatment Strategies
    • Technological Convergence with AI and Machine Learning Strengthens Business Case for Personalized NTD Interventions
    • Challenges in Supply Chain and Distribution Networks Create Bottlenecks to Market Penetration
    • Socioeconomic Burden of NTDs Drives Multilateral Commitments to Drug Availability
    • Greater Engagement from Emerging Market Pharmaceutical Companies Expands Treatment Accessibility
    • Rising Awareness Campaigns and Community Engagement Models Spur Uptake of NTD Medications
    • Policy-Driven Integration of NTD Care in Primary Healthcare Systems Generates Demand for Combination Therapies
    • Pressure to Develop Pediatric and Gender-Sensitive Formulations Drives Innovation in Inclusive Drug Design
    • Adoption of Open-Source Research Platforms Accelerates Development of Cost-Effective Treatments
    • Evolving Patent Expirations and Generic Drug Entry Opens Up Price-Competitive Market Landscape
    • Decentralization of Healthcare Services in Rural Regions Sustains Growth in Localized Treatment Models
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Neglected Tropical Disease Treatment Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Neglected Tropical Disease Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Neglected Tropical Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for NTD Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for NTD Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for NTD Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for NTD Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for NTD Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for NTD Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Human African Trypanosomiasis Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Human African Trypanosomiasis Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Human African Trypanosomiasis Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Leishmaniases Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Leishmaniases Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Leishmaniases Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Soil-Transmitted Helminthiases Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Soil-Transmitted Helminthiases Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Soil-Transmitted Helminthiases Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Disease Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Disease Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Other Disease Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Dengue Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Dengue Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Dengue Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Rabies Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Rabies Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Rabies Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Trachoma Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Trachoma Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Trachoma Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Buruli Ulcer Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Buruli Ulcer Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Buruli Ulcer Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Yaws Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Yaws Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Yaws Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Leprosy Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Leprosy Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Leprosy Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Chagas Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Chagas Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Chagas Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neglected Tropical Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
  • JAPAN
    • Neglected Tropical Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
  • CHINA
    • Neglected Tropical Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
  • EUROPE
    • Neglected Tropical Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Neglected Tropical Disease Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Neglected Tropical Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
  • FRANCE
    • Neglected Tropical Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
  • GERMANY
    • Neglected Tropical Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Germany 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 89: Italy Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Italy Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Italy 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Italy 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Neglected Tropical Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 95: UK Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: UK Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: UK 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
    • TABLE 98: UK Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: UK 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 101: Spain Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Spain Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Spain 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
    • TABLE 104: Spain Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Spain Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Spain 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 107: Russia Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Russia Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Russia 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
    • TABLE 110: Russia Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Russia Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Russia 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Rest of Europe 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Rest of Europe 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Neglected Tropical Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 120: Asia-Pacific Historic Review for Neglected Tropical Disease Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Asia-Pacific 15-Year Perspective for Neglected Tropical Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Asia-Pacific 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Asia-Pacific 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Neglected Tropical Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 128: Australia Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Australia Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Australia 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
    • TABLE 131: Australia Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Australia Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Australia 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
  • INDIA
    • Neglected Tropical Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 134: India Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: India Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: India 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
    • TABLE 137: India Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: India Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: India 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 140: South Korea Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: South Korea Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: South Korea 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
    • TABLE 143: South Korea Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: South Korea Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: South Korea 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 146: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Asia-Pacific Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Asia-Pacific 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
    • TABLE 149: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Asia-Pacific Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of Asia-Pacific 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Neglected Tropical Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 152: Latin America Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 153: Latin America Historic Review for Neglected Tropical Disease Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Latin America 15-Year Perspective for Neglected Tropical Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 155: Latin America Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Latin America Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Latin America 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
    • TABLE 158: Latin America Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Latin America Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Latin America 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 161: Argentina Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Argentina Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Argentina 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
    • TABLE 164: Argentina Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Argentina Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Argentina 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 167: Brazil Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Brazil Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Brazil 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
    • TABLE 170: Brazil Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Brazil Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Brazil 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 173: Mexico Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Mexico Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Mexico 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
    • TABLE 176: Mexico Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Mexico Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Mexico 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 179: Rest of Latin America Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Latin America Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Latin America 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Latin America Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Latin America Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Latin America 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Neglected Tropical Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 185: Middle East Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 186: Middle East Historic Review for Neglected Tropical Disease Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Middle East 15-Year Perspective for Neglected Tropical Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 188: Middle East Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Middle East Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Middle East 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
    • TABLE 191: Middle East Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Middle East Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Middle East 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 194: Iran Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Iran Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Iran 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
    • TABLE 197: Iran Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Iran Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Iran 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 200: Israel Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Israel Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Israel 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
    • TABLE 203: Israel Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Israel Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Israel 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 206: Saudi Arabia Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Saudi Arabia Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Saudi Arabia 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
    • TABLE 209: Saudi Arabia Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Saudi Arabia Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Saudi Arabia 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 212: UAE Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: UAE Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: UAE 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
    • TABLE 215: UAE Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: UAE Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: UAE 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 218: Rest of Middle East Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Rest of Middle East Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Rest of Middle East 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
    • TABLE 221: Rest of Middle East Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Rest of Middle East Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Rest of Middle East 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030
  • AFRICA
    • Neglected Tropical Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 224: Africa Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Africa Historic Review for Neglected Tropical Disease Treatment by Product Type - NTD Drugs and NTD Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Africa 15-Year Perspective for Neglected Tropical Disease Treatment by Product Type - Percentage Breakdown of Value Sales for NTD Drugs and NTD Vaccines for the Years 2015, 2025 & 2030
    • TABLE 227: Africa Recent Past, Current & Future Analysis for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Africa Historic Review for Neglected Tropical Disease Treatment by Disease Type - Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Africa 15-Year Perspective for Neglected Tropical Disease Treatment by Disease Type - Percentage Breakdown of Value Sales for Human African Trypanosomiasis Disease, Leishmaniases Disease, Soil-Transmitted Helminthiases Disease, Other Disease Types, Dengue Disease, Rabies Disease, Trachoma Disease, Buruli Ulcer Disease, Yaws Disease, Leprosy Disease and Chagas Disease for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제